BioCentury | Feb 14, 2008
Distillery Therapeutics

This Week in Therapeutics

...Ka (CLCNKA); chloride channel Kb (CLCNKB) An in vitro study identified benzofuran derivatives that inhibited CLCNKA and CLCNKB...
...used to boost CLCNKB channels in Bartter syndrome, a rare genetic disease involving mutations in CLCNKB...
Items per page:
1 - 1 of 1